The substantial role of initial ribavirin dose on the response to peginterferon alpha/ribavirin therapy in patients with genotype 1b chronic hepatitis C.
作者信息
Dai Chia-Yen, Huang Chung-Feng, Chuang Wan-Long, Huang Jee-Fu, Yu Ming-Lung
出版信息
Am J Gastroenterol. 2009 Sep;104(9):2358-9. doi: 10.1038/ajg.2009.246.
PMID:19727098
Abstract
摘要
相似文献
1
The substantial role of initial ribavirin dose on the response to peginterferon alpha/ribavirin therapy in patients with genotype 1b chronic hepatitis C.
Am J Gastroenterol. 2009 Sep;104(9):2358-9. doi: 10.1038/ajg.2009.246.
2
Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection.
Hepatology. 2008 Aug;48(2):695. doi: 10.1002/hep.22450.
3
Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virological response.
Hepatology. 2010 Oct;52(4):1519-20; author reply 1520-1. doi: 10.1002/hep.23925.
4
Extending combination therapy with peginterferon alfa-2b plus ribavirin for genotype 1 chronic hepatitis C late responders: a report of 9 cases.
Hepatology. 2003 May;37(5):1226-7. doi: 10.1053/jhep.2003.50107.
5
Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C.
Am J Gastroenterol. 2004 Aug;99(8):1490-6. doi: 10.1111/j.1572-0241.2004.30286.x.
6
Peginterferon Alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection.
N Engl J Med. 2005 Sep 15;353(11):1182-3; author reply 1182-3.
7
[Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection].
Korean J Hepatol. 2008 Sep;14(3):318-30. doi: 10.3350/kjhep.2008.14.3.318.
8
[Patient, 50, with chronic hepatitis C genotype 1 infection. Therapeutic success despite poor prognosis].
MMW Fortschr Med. 2003 Oct 9;145(41):39-40.
9
Peginterferon Alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection.
N Engl J Med. 2005 Sep 15;353(11):1182-3; author reply 1182-3. doi: 10.1056/NEJMc052008.
10
[Effectiveness of long-acting interferon (peginterferon)].
Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):515-8.
Zotero 插件